I Kappa B Kinase Inhibitors (Kyorin)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameI Kappa B Kinase Inhibitors (Kyorin)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of NF-kappa-B kinase (IKK) inhibitors
TargetsInhibitor of NF-kappa-B kinase (IKK)
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyorin Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyorin Holdings Inc
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A